Table 1.
Patient and donor characteristics.
| Patients | |
| Number (n) | 99 |
| Age (median, range) | 45, 6–65 |
| Gender (female/male) | 54/45 |
| Type of transplantation (alternative/SIB) | 59/40 |
| Transplant material (PBPCs/BM) | 94/4 1 PBPCs + BM |
| Diagnosis | |
| AML | 53 |
| ALL | 23 |
| Other lymphoproliferative disorders | 3 |
| Myeloproliferative disorders | 9 |
| Myelodysplastic syndrome | 11 |
| Conditioning regimen: | |
| Myeloablative | 67 |
| Reduced intensity | 32 |
| aGvHD grade | |
| 0 | 55 |
| I | 14 |
| II | 13 |
| III | 5 |
| IV | 12 |
| CMV IgG serostatus | |
| anti-CMV-IgG negative | 20 |
| anti-CMV-IgG positive | 78 |
| Data not available | 1 |
| Donors | |
| Age (median, range) | 37, 19–62 |
| SIB donors (median, range) | 44, 19–62 |
| MUD donors (median, range) | 31, 20–54 |
| Gender (female/male) | 31, 48/51 |
| CMV IgG serostatus | |
| anti-CMV-IgG negative | 33 |
| anti-CMV-IgG positive | 64 |
| Data not available | 2 |